Tuesday, January 11, 2022

Matricelf treats pig's spinal cord injury with human implants


Xenotransplantation in both directions at about the same time!

"Israeli biotech company Matricelf (TASE: MTLF) today reported that it has successfully completed another usability trial with human implants for replacing the injured spinal cord of a living pig. The company is developing autologous (bone marrow) implants for the regeneration of damaged tissues by using stem cells and external stem cell components from the patients themselves.

Conducting the trial in the live pig simulates the anticipated surgical procedure in humans, both in terms of the flow of brain and spinal fluids (cerebrospinal fluid - CSF) and in terms of the bleeding that might be created near the site of the injury. During the trial, the company was successful in positioning, by two neurosurgeons, human implants (that is to say neural implants originating from human tissues) developed by the company, in the injured spinal cord of the living pig. After the placement of the implants in the area of the injury, a substitute Dura Patch was grafted into the injured spinal cord, as is done with humans, the membranes surrounding the spinal cord were sutured back together, and the trial was completed with major success. ..."

Matricelf treats pig's spinal cord injury with human implants - Globes The company is developing implants for the regeneration of damaged tissues by using stem cells from the patients themselves.

No comments: